The tolerability and pharmacokinetics of N-butyl-deoxynojirimycin in patients with advanced HIV disease (ACTG 100). The AIDS Clinical Trials Group (ACTG) of the National Institute of Allergy and Infectious Diseases.

The tolerability and pharmacokinetics of N-butyl-deoxynojirimycin in patients with advanced HIV disease (ACTG 100). The AIDS Clinical Trials Group (ACTG) of the National Institute of Allergy and Infectious Diseases.

Item
http://www.wikidata.org/entity/Q33485537
N-Glycan-based ER Molecular Chaperone and Protein Quality Control System: The Calnexin Binding CycleIdentifying chemicals with potential therapy of HIV based on protein-protein and protein-chemical interaction networkMinimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig ModelGaucher disease and the clinical experience with substrate reduction therapy.The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?GPG-NH2 acts via the metabolite alphaHGA to target HIV-1 Env to the ER-associated protein degradation pathway.Clinical importance of HIV and depressive symptoms among veterans with HIV infection.Review of miglustat for clinical management in Gaucher disease type 1.Complementation of a pathogenic IFNGR2 misfolding mutation with modifiers of N-glycosylation.Iminosugar antivirals: the therapeutic sweet spot.Drug repositioning can accelerate discovery of pharmacological chaperones.E-Learning for Rare Diseases: An Example Using Fabry Disease.
P2860

The tolerability and pharmacokinetics of N-butyl-deoxynojirimycin in patients with advanced HIV disease (ACTG 100). The AIDS Clinical Trials Group (ACTG) of the National Institute of Allergy and Infectious Diseases.

Item
http://www.wikidata.org/entity/Q33485537
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
The tolerability and pharmacok ...... lergy and Infectious Diseases.
@ast
The tolerability and pharmacok ...... lergy and Infectious Diseases.
@en
type
label
The tolerability and pharmacok ...... lergy and Infectious Diseases.
@ast
The tolerability and pharmacok ...... lergy and Infectious Diseases.
@en
prefLabel
The tolerability and pharmacok ...... lergy and Infectious Diseases.
@ast
The tolerability and pharmacok ...... lergy and Infectious Diseases.
@en
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P921
P1433
P1476
The tolerability and pharmacok ...... lergy and Infectious Diseases.
@en
P2093
P304
P31
P407
P433
P478
P577
P698
P921